Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-10

FDA Approved: METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, a generic combination product for hypertension manufactured by Mylan Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE (metoprolol tartrate and hydrochlorothiazide)

Snippet

SUPPL AP for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE (METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE)